Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, oral tobacco products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in transportation, power generation, real estate, and manufacturing equipment industries. The company sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
IPO Year:
Exchange: NYSE
Website: altria.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/8/2024 | $44.50 → $48.00 | Neutral | Citigroup |
| 1/23/2024 | Sell | UBS | |
| 4/14/2023 | $52.00 | Buy | Stifel |
| 11/10/2022 | $38.00 | Neutral → Sell | UBS |
| 6/29/2022 | $53.00 → $36.00 | Equal Weight → Underweight | Barclays |
| 6/24/2022 | $47.00 → $43.00 | Underweight → Equal-Weight | Morgan Stanley |
| 6/8/2022 | $54.00 → $50.00 | Equal-Weight → Underweight | Morgan Stanley |
| 5/10/2022 | $58.00 → $53.00 | Outperform → Mkt Perform | Bernstein |
| 3/28/2022 | $53.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 3/22/2022 | $48.00 → $57.00 | Neutral → Buy | Goldman |
Altria Group, Inc. (NYSE:MO) today reports our 2024 third-quarter and nine-months business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria delivered outstanding results in the third quarter," said Billy Gifford, Altria's Chief Executive Officer. "The smokeable products segment delivered solid operating companies income growth behind the resilience of Marlboro, and in the oral tobacco products segment, our MST brands continued to drive profitability while on! maintained momentum in the marketplace. We also continued to reward shareholders through a growing dividend and share repurchases while making investments in pursuit of our Visio
Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Thursday, October 31, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 third-quarter and nine-months business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Chief Financial Officer, will discuss the Company's 2024 third-quarter and nine-months business results and answer questions from the investment community and news media. The webcast will be in a listen-only mode. Pre-event registration is neces
Altria Group, Inc. (NYSE:MO) and its operating company NJOY today respond to the U.S. International Trade Commission (ITC) Administrative Law Judge's (ALJ) initial determination regarding the patent infringement complaint JUUL Labs, Inc. (JUUL) filed against NJOY. Last week, the ALJ provided notice of her initial determination supporting JUUL's allegations in its complaint and recommending an exclusion order that would prohibit the importation of NJOY ACE (ACE) into the United States. Altria and NJOY respectfully disagree with the ALJ's initial determination, and NJOY looks forward to presenting its position to the full ITC, which is expected to issue a final decision by December 23, 20
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors voted to increase our regular quarterly dividend by 4.1% to $1.02 per share versus the previous rate of $0.98 per share. The quarterly dividend is payable on October 10, 2024 to shareholders of record as of September 16, 2024. The ex-dividend date is September 16, 2024. The new annualized dividend rate is $4.08 per share, representing a dividend yield of 7.9% based on our closing stock price of $51.81 on August 21, 2024. Today's dividend increase is consistent with our progressive dividend goal that targets mid-single digits dividend per share growth annually through 2028. This increase marks the 59th dividend incr
Altria Group, Inc. (NYSE:MO) today reports our 2024 second-quarter and first-half business results and narrows our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria's momentum continues to build as we pursue our Vision to responsibly lead the transition of adult smokers to a smoke-free future," said Billy Gifford, Altria's Chief Executive Officer. "In the second quarter, our companies' innovative smoke-free products delivered strong share and volume performance, and we hit meaningful milestones that we believe set us up for future success. NJOY received the first and only marketing granted orders from the FDA for menthol e-vapor products, and we submitted PMTA
Altria Group, Inc. (Altria) (NYSE:MO) will host a live audio webcast on Wednesday, July 31, 2024, at 9:00 a.m. Eastern Time to discuss its 2024 second-quarter and first-half business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Chief Financial Officer, will discuss the Company's 2024 second-quarter and first-half business results and answer questions from the investment community and news media. The webcast will be in a listen-only mode. Pre-event registration is neces
Today, Altria Group, Inc. (Altria) announces the submission of Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration (FDA) for its innovative on! PLUS oral nicotine pouch products. The PMTAs were submitted by Altria's wholly owned subsidiary Helix Innovations LLC (Helix). on! PLUS is a spit-free, oral tobacco-derived nicotine (TDN) pouch product made from a proprietary "soft-feel" material to provide a more comfortable product experience. The on! PLUS pouch is designed for adults who dip and adult dual users (i.e., adults who smoke and dip). on! PLUS pouches are seamless and larger than the leading U.S. TDN brands. Similar to the currently marketed on!® p
Altria Group, Inc. (Altria) (NYSE:MO) announces today that the U.S. Food and Drug Administration (FDA) issued marketing orders for NJOY ACE Pod Menthol 2.4%, NJOY ACE Pod Menthol 5%, NJOY DAILY Menthol 4.5%, and NJOY DAILY Extra Menthol 6%. These authorizations follow FDA review of the Premarket Tobacco Product Applications (PMTA), submitted by NJOY, LLC (NJOY) in March 2020. NJOY ACE remains the only pod-based e-vapor product with marketing authorization from the FDA, and now NJOY has the first and only menthol e-vapor products authorized by the FDA to date. "Altria is Moving Beyond Smoking™, taking action to transition millions of adult smokers to potentially less harmful alternatives.
Today, NJOY, an Altria company, announces the submission of a supplemental Premarket Tobacco Product Application (PMTA) to the U.S. Food and Drug Administration (FDA) to commercialize and market the NJOY ACE 2.0 device. This new device incorporates access restriction technology designed to prevent underage use via Bluetooth® connectivity to authenticate the user before unlocking the device. The company also re-submitted PMTAs for Blueberry and Watermelon pod products that work exclusively with the NJOY ACE 2.0 device. "Altria's Vision is to responsibly lead the transition of adult smokers to a smoke-free future. We're excited to build on our existing FDA-authorized products. NJOY ACE 2.0
Altria Group, Inc. (Altria) (NYSE:MO) held our 2024 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria's Chief Executive Officer, provided brief remarks and addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on www.altria.com. Preliminary Voting Results The preliminary voting results from our shareholders at the Annual Meeting were as follows: elected to a one-year term each of the 10 nominees for our Board of Directors (Board) named in our 2024 Proxy Statement; ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
4 - ALTRIA GROUP, INC. (0000764180) (Issuer)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G - ALTRIA GROUP, INC. (0000764180) (Subject)
SC 13G/A - ALTRIA GROUP, INC. (0000764180) (Subject)
Altria Group, Inc. (NYSE:MO) today reports our 2024 third-quarter and nine-months business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria delivered outstanding results in the third quarter," said Billy Gifford, Altria's Chief Executive Officer. "The smokeable products segment delivered solid operating companies income growth behind the resilience of Marlboro, and in the oral tobacco products segment, our MST brands continued to drive profitability while on! maintained momentum in the marketplace. We also continued to reward shareholders through a growing dividend and share repurchases while making investments in pursuit of our Visio
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors voted to increase our regular quarterly dividend by 4.1% to $1.02 per share versus the previous rate of $0.98 per share. The quarterly dividend is payable on October 10, 2024 to shareholders of record as of September 16, 2024. The ex-dividend date is September 16, 2024. The new annualized dividend rate is $4.08 per share, representing a dividend yield of 7.9% based on our closing stock price of $51.81 on August 21, 2024. Today's dividend increase is consistent with our progressive dividend goal that targets mid-single digits dividend per share growth annually through 2028. This increase marks the 59th dividend incr
Altria Group, Inc. (NYSE:MO) today reports our 2024 second-quarter and first-half business results and narrows our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "Altria's momentum continues to build as we pursue our Vision to responsibly lead the transition of adult smokers to a smoke-free future," said Billy Gifford, Altria's Chief Executive Officer. "In the second quarter, our companies' innovative smoke-free products delivered strong share and volume performance, and we hit meaningful milestones that we believe set us up for future success. NJOY received the first and only marketing granted orders from the FDA for menthol e-vapor products, and we submitted PMTA
Altria Group, Inc. (Altria) (NYSE:MO) held our 2024 Annual Meeting of Shareholders (Annual Meeting) today. During the Annual Meeting, Billy Gifford, Altria's Chief Executive Officer, provided brief remarks and addressed shareholder questions. A copy of the presentation and a replay of the webcast are available on www.altria.com. Preliminary Voting Results The preliminary voting results from our shareholders at the Annual Meeting were as follows: elected to a one-year term each of the 10 nominees for our Board of Directors (Board) named in our 2024 Proxy Statement; ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2
Altria Group, Inc. (NYSE:MO) today reports our 2024 first-quarter business results and reaffirms our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "We made meaningful progress in pursuit of our Vision, and our highly profitable traditional tobacco businesses continued to perform well in a challenging environment," said Billy Gifford, Altria's Chief Executive Officer. "In spite of the absence of an effective regulatory environment, we saw continued early momentum from NJOY and believe our businesses are on track to deliver against full-year plans." "We also demonstrated our continued commitment to maximizing the return on our investments and delivering strong sha
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $0.98 per share, payable on April 30, 2024 to shareholders of record as of March 25, 2024. The ex-dividend date is March 22, 2024. View source version on businesswire.com: https://www.businesswire.com/news/home/20240228625112/en/
Altria Group, Inc. (NYSE:MO) today reports our 2023 fourth-quarter and full-year business results and provides our guidance for 2024 full-year adjusted diluted earnings per share (EPS). "It was a pivotal year for Altria as we made significant progress in pursuit of our Vision by enhancing our smoke-free product portfolio while our businesses performed well in a challenging environment," said Billy Gifford, Altria's Chief Executive Officer. "We grew adjusted diluted EPS by 2.3% and continued our long history of rewarding shareholders by delivering nearly $7.8 billion in dividends and share repurchases." "Our plans for 2024 include a continuation of our strategy to balance earnings growth
Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $0.98 per share, payable on January 10, 2024 to shareholders of record as of December 21, 2023. The ex-dividend date is December 20, 2023. View source version on businesswire.com: https://www.businesswire.com/news/home/20231206243816/en/
Altria Group, Inc. (NYSE:MO) today reports our 2023 third-quarter and nine-months business results and narrows our guidance for 2023 full-year adjusted diluted earnings per share (EPS). "Our highly profitable traditional tobacco businesses were resilient in a dynamic operating environment during the third quarter and first nine months, providing fuel for our business transformation and significant cash returns to our shareholders," said Billy Gifford, Altria's Chief Executive Officer. "I believe we have the appropriate strategies and people in place to execute our growth plans. I continue to believe that we can achieve our Vision and create long-term value for our shareholders." "We are
Altria Group, Inc. (NYSE:MO) today reports our 2023 second-quarter and first-half business results and reaffirms our guidance for 2023 full-year adjusted diluted earnings per share (EPS). "We had a solid first half of the year and we continue on our exciting journey towards Moving Beyond Smoking," said Billy Gifford, Altria's Chief Executive Officer. "We completed our acquisition of NJOY and delivered strong business results, growing adjusted diluted EPS by 5% in the first half. And we returned $3.8 billion to shareholders while investing in pursuit of our Vision." "We look forward to executing our commercial plan for NJOY in the second half of the year, and we reaffirm our guidance to
10-Q - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
10-Q - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
11-K - ALTRIA GROUP, INC. (0000764180) (Filer)
11-K - ALTRIA GROUP, INC. (0000764180) (Filer)
10-K/A - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
10-Q - ALTRIA GROUP, INC. (0000764180) (Filer)
8-K - ALTRIA GROUP, INC. (0000764180) (Filer)
Citigroup reiterated coverage of Altria with a rating of Neutral and set a new price target of $48.00 from $44.50 previously
UBS resumed coverage of Altria with a rating of Sell
Stifel resumed coverage of Altria with a rating of Buy and set a new price target of $52.00
UBS downgraded Altria from Neutral to Sell and set a new price target of $38.00
Barclays downgraded Altria from Equal Weight to Underweight and set a new price target of $36.00 from $53.00 previously
Morgan Stanley upgraded Altria from Underweight to Equal-Weight and set a new price target of $43.00 from $47.00 previously
Morgan Stanley downgraded Altria from Equal-Weight to Underweight and set a new price target of $50.00 from $54.00 previously
Bernstein downgraded Altria from Outperform to Mkt Perform and set a new price target of $53.00 from $58.00 previously
RBC Capital Mkts downgraded Altria from Outperform to Sector Perform and set a new price target of $53.00
Goldman upgraded Altria from Neutral to Buy and set a new price target of $57.00 from $48.00 previously
As of July 25, 2024, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here's the latest list of major overbought players in this sector. Unilever plc (NYSE:UL) On July 25, Unilever reported quarterly adjusted earnings of $1
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector. Kellanova (NYSE:K) Dividend Yield: 3.96% B of A Securities analyst Bryan Spillane maintained a Neutral rating and cut the
Investors with a lot of money to spend have taken a bullish stance on Altria Group (NYSE:MO). And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MO, it often means somebody knows something is about to happen. So how do we know what these investors just did? Today, Benzinga's options scanner spotted 14 uncommon options trades for Altria Group. This isn't normal. The overall sentiment of these big-money traders is split between 57% bullish and 28%, bearish. Out of all of the specia
Senator Elizabeth Warren (D-MA) delivered a compelling call for the careful legalization of cannabis at a weekend event sponsored by the Parabola Center, a nonpartisan think tank dedicated to equity in cannabis advocacy. TV personality Jonathan Van Ness of the Netflix series “Queer Eye” was also in attendance. The two-day gathering featured a series of discussions and an "anti-monopoly cannabis crash course." "Legalizing marijuana is about more than just allowing recreational use or the money that can be made from this new market, or even about the potential medicinal benefits," Warren said via a prerecorded video. "It's about undoing a century of racist policy that disproportionately
Altria Group's (NYSE:MO) short percent of float has fallen 15.38% since its last report. The company recently reported that it has 26.47 million shares sold short, which is 1.54% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.14 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest
B of A Securities analyst Lisa Lewandowski maintains Altria Group (NYSE:MO) with a Neutral and raises the price target from $47 to $48.
Breweries in Minneapolis now offer hemp-derived, THC-infused drinks on tap, thanks to a new Minnesota law effective July 1. This change allows taprooms to serve these drinks on tap, not only in cans, provided they display the required label information. Dan Schnabel, taproom manager at Headflyer Brewing, told CBS that his team anticipated the statute change and quickly adapted. "Having it on tap gives us so many different options for our consumers to taste it, to try it, to enjoy one while they're here on site," Schnabel said. Regulations Made It Possible This development follows the legalization of THC edibles derived from hemp two years ago, which are capped at 5 milligrams per serving
- Bloomberg
https://www.statnews.com/2024/06/28/vape-makers-fda-supreme-court-chevron-doctrine/WASHINGTON — Vape manufacturers are taking a victory lap over a Supreme Court decision that could dramatically weaken the Food and Drug Administration's power to regulate tobacco and nicotine products as regulators see fit.The court on Friday overturned a judicial rule, known as the Chevron doctrine, which instructed courts to defer to regulators on certain legal issues. Vape manufacturers see the decision as a powerful weapon in their fight against the FDA's efforts to ban the majority of vapes lining store shelves.The FDA has argued that its decision to ban more than 1 million vapes is in line with a 2009 la
Jacinto J. Hernandez, a director of Altria Group, Inc. ("Altria"), retired from service on our Board of Directors effective February 23, 2024. Mr. Hernandez will continue to serve Altria as a strategic advisor under a 5-year advisory services agreement. "We thank Jacinto for his service on our Board," said Kathryn McQuade, Altria's independent Board Chair. "Our Board benefited from his industry experience and financial expertise." "I joined Altria's Board because I am inspired by Altria's Vision to responsibly lead the transition of adult smokers to a smoke-free future," said Mr. Hernandez. "I am pleased that this agreement will allow me to focus my attention on helping Altria pursue it
-Yzaguirre joins a list of seasoned professionals on FireFly's team with specific expertise in initiating and growing businesses in evolving market conditions- FireFly Automatix, Inc., the de facto industry leader in AV and EV professional turfgrass mowing technology, today announced the appointment of financial and leadership expert M. Max Yzaguirre as a strategic advisor to CEO Andrew Limpert and the board of directors. Yzaguirre's appointment follows the recent additions of former WPP Group CFO Paul Richardson and capital markets professional Liz Hocker to FireFly's board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202401
Nabil Y. Sakkab, a director of Altria Group, Inc. ("Altria") since 2008, will retire from service on our Board of Directors following the completion of his current term. Consequently, Mr. Sakkab will not stand for re-election to the Board of Directors at Altria's 2024 Annual Meeting of Shareholders, which Altria anticipates holding on May 16, 2024. "Nabil's contributions have significantly benefited Altria over the past 15 years," said Kathryn McQuade, Altria's independent Chair of the Board. "We thank him for his long and distinguished service and wish him the very best upon his retirement." Dr. Sakkab is Chair of the Innovation Committee and is a member of the Executive, Finance, and
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of late-stage microdose array print (MAP™) therapeutics, today announced that it has appointed Dr. Ellen Strahlman and Dr. Ram Palanki as new and independent members of its Board of Directors. With these appointments, the Eyenovia Board will expand to eight seats, from six currently. "I could not be more pleased to welcome Drs. Strahlman and Palanki to our Board and look forward to their immediate contributions," stated Dr. Sean Ianchulev, chief executive officer and chief medical officer of Eyenovia. "Each brings decades of medical technology, cl
RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE: MO) is participating today in the Morgan Stanley Global Consumer and Retail Conference. Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso, Chief Financial Officer, will host virtual meetings with investors to discuss Altria's business fundamentals. 2020 Full-Year Guidance Altria reaffirms its guidance for 2020 full-year adjusted diluted earnings per share (EPS) to be in a range of $4.30 to $4.38. This range represents a growth rate of 2% to 4% from an adjusted diluted EPS base of $4.21 in 2019, as shown in Schedule 1, and excludes the special items recorded in the first nine months of 2020, also sh